Lee Chin Hyok

Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗

Lifetime net: $0

Positions by company

Reported holding is the most recent post-transaction share count on a Table I row.

Every company this insider has reported trading in, with the value bought and sold at each and the date they last traded.
Ticker	Company	Bought	Sold	Net	Shares held	Last trade
LYCA	Lycia Therapeutics, Inc.	$0	$0	$0	—	Aug 11

LYCA

Lycia Therapeutics, Inc.

Bought

Sold

Held

—

Filing record

How quickly this filer reports. Section 16 allows two business days from the transaction.

1 of 1 filing we hold was filed after the two-business-day deadline. The furthest past the deadline was 50 business days late.

Form 4 filings made after the two-business-day deadline, with the transaction date, the filing date and the number of business days between them.
Traded	Filed	Company	Past deadline	Largest line	Source
Aug 11	Oct 26	LYCALycia Therapeutics, Inc.	50days · about 2 months	—	Filing ↗

LYCA

Lycia Therapeutics, Inc.

50days · about 2 months

Traded Aug 11 · filed Oct 26Filing ↗

Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays.

Trade history

The 1 most recent Form 4 transactions.

Insider transactions, newest first: date, security, transaction type, size and a link to the filing each row came from.
Date	Ticker	Company	Type	Shares	Price	Value	Δ Own	Filing
Aug 11	LYCA	Lycia Therapeutics, Inc.	AGRANT◆	73,191	—	—	—	Open the original filing on SEC.gov

LYCAAGRANT◆—

Lycia Therapeutics, Inc.